Biofrontera AG 4
4 · Biofrontera Inc. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Biofrontera Inc.BFRI
Biofrontera AG
Director10% Owner
Transactions
- Purchase
Series D Convertible Preferred Stock
2025-09-16+3,019→ 3,019 totalExercise: $0.00→ Common Stock (4,831,172 underlying)
Footnotes (2)
- [F1]The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.
- [F2]The reporting person acquired the convertible preferred stock in a privately negotiated transaction in exchange for assets related to the production and sale of certain products in the United States having an estimated market value of approximately $3,019,000.